EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply

Søren S Olesen iD, Asbjørn M Drewes iD

Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 1019-1020

DOI: 10.1111/apt.70854 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 10.07.2026. Verfasst von Søren S Olesen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

ORCID-Profile: Søren S Olesen, Asbjørn M Drewes

Zitieren

APA

Olesen, S. S., & Drewes, A. M. (2026). Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(7), 1019-1020. https://doi.org/10.1111/apt.70854

Vancouver

Olesen SS, Drewes AM. Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(7):1019-1020. doi:10.1111/apt.70854

BibTeX
@article{Olesen2026,
  author = {Olesen, Søren S and Drewes, Asbjørn M},
  title = {Letter: Severity‐Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {7},
  pages = {1019--1020},
  doi = {10.1111/apt.70854}
}
Kostenlos starten →